Original ArticleClinical, microbial efficacy and tolerability of Elores, a novel antibiotic adjuvant entity in ESBL producing pathogens: Prospective randomized controlled clinical trial
Keywords
Antibiotic adjuvant entity
Clinical trial
Phase-III
Elores
Cited by (0)
Copyright © 2013 JPR Solutions. Published by Reed Elsevier India, Pvt. Ltd. All rights reserved.